To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TSEN54TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
212 supporting clones for gene TSEN54 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX424294 T cells (Jurkat cell line) .a 1 to 934 1 to 938   tiling clone, fully sequenced,   938/938
(100 %)
11 diff
(98.9 %id)
CT002637 T-Lymphocytes .a 551 to 1377 1 to 828   tiling clone,   828/828
(100 %)
4 diff
(99.6 %id)
BQ709928 Spleen .a 605 to 1402 1 to 806   tiling clone,   806/947
(85 %)
37 diff
(96.1 %id)
BX424293 T cells (Jurkat cell line) .a 924 to 2055 1128 to 8   tiling clone, fully sequenced,   1121/1128
(99 %)
42 diff
(96.3 %id)
BG248948 hypernephroma, cell line, Kidney .a 1026 to 1869 1 to 842   tiling clone,   842/919
(91 %)
42 diff
(95.5 %id)
AA377610 synovial membrane .a 1413 to 1630 1 to 219       219/233
(93 %)
6 diff
(97.5 %id)
AA370164 Prostate .a 1445 to 1663 1 to 219   tiling clone,   219/219
(100 %)
3 diff
(98.7 %id)
AK097583 testis .b 1 to 2529 1 to 1682 F30S P238A P239S C240G S241T ... tiling clone, available from FLJ, Suspected internal deletion 1682/1682
(100 %)
2 diff
(99.9 %id)
BM923126 leukocyte .c 1 to 869 9 to 887   tiling clone,   879/1102
(79 %)
28 diff
(97.5 %id)
BE247638 leukopheresis .c 8 to 300 1 to 295       295/295
(100 %)
8 diff
(97.3 %id)
BM152385 leukopheresis .c 8 to 345 1 to 338       338/338
(100 %)
5 diff
(98.6 %id)
NM_207346.2   .c 9 to 1949 1 to 1941   RefSeq, AAA   1941/1941
(100 %)
0 diff
(100 %id)
BF205772 muscle, rhabdomyosarcoma .c 11 to 666 1 to 654       654/1095
(59 %)
13 diff
(98.9 %id)
BG707852 brain, hypothalamus .c 11 to 626 1 to 614       614/614
(100 %)
5 diff
(99.2 %id)
BI598142 brain, hypothalamus .c 11 to 664 1 to 652       652/665
(98 %)
8 diff
(98.8 %id)
TI_45216726   .c 12 to 664 122 to 772       651/785
(82 %)
11 diff
(98.6 %id)
BM762463 myeloma .c 18 to 632 1 to 615   tiling clone,   615/615
(100 %)
0 diff
(100 %id)
BM847178 myeloma .c 18 to 572 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BM848087 myeloma .c 18 to 517 1 to 500       500/500
(100 %)
0 diff
(100 %id)
BM845193 myeloma .c 18 to 254 1 to 237       237/237
(100 %)
4 diff
(98.4 %id)
BQ924972 large cell carcinoma, lung .c 20 to 852 1 to 840       840/840
(100 %)
12 diff
(98.6 %id)
BX363212   .c 21 to 640 1 to 622       622/622
(100 %)
17 diff
(97.3 %id)
BQ953188 epidermoid carcinoma, cell line, lung .c 23 to 777 10 to 778       767/955
(80 %)
42 diff
(95.7 %id)
BX421781 T cells (Jurkat cell line) .c 25 to 1120 1 to 1091       1091/1091
(100 %)
20 diff
(98.2 %id)
BI088589 cervix .c 25 to 666 1 to 642       642/656
(97 %)
5 diff
(99.3 %id)
CR980431 T-Lymphocytes .c 25 to 799 1 to 775       775/779
(99 %)
4 diff
(99.5 %id)
CR992467 T-Lymphocytes .c 27 to 540 1 to 514       514/514
(100 %)
1 diff
(99.9 %id)
BX401839   .c 28 to 1002 1 to 967       967/997
(96 %)
45 diff
(95.5 %id)
BG709523 brain, hypothalamus .c 28 to 798 1 to 777   available from MGC,   776/787
(98 %)
31 diff
(96.1 %id)
AL519645 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 32 to 962 1 to 924   fully sequenced,   924/924
(100 %)
10 diff
(99.0 %id)
BI911680 leukocyte .c 32 to 681 22 to 673   available from MGC,   652/673
(96 %)
14 diff
(98.0 %id)
TI_57233524   .c 32 to 681 22 to 673       652/673
(96 %)
14 diff
(98.0 %id)
TI_57200359   .c 35 to 940 23 to 913       891/925
(96 %)
26 diff
(97.2 %id)
TI_57200511   .c 35 to 702 24 to 698       675/699
(96 %)
14 diff
(98.0 %id)
DB491965.
matches multiple genes
hypothalamus .c 36 to 467 1 to 432     also hits gene nituru 432/439
(98 %)
3 diff
(99.4 %id)
BQ934662 sciatic nerve .c 36 to 720 1 to 697       697/964
(72 %)
17 diff
(98.3 %id)
BX341742   .c 38 to 920 1 to 885       885/885
(100 %)
13 diff
(98.6 %id)
BC053643 Blood, adult leukocytes .c 38 to 1949 1 to 1912 E4D K347N A437V tiling clone, available from MGC, AAA   1912/1912
(100 %)
4 diff
(99.8 %id)
TI_57163140   .c 38 to 741 55 to 759       705/759
(92 %)
10 diff
(98.7 %id)
BX346395   .c 39 to 935 1 to 890   fully sequenced,   890/890
(100 %)
9 diff
(99.0 %id)
TI_1948213296   .c 39 to 619 123 to 700       578/1308
(44 %)
19 diff
(98.6 %id)
TI_1948213297   .c 39 to 931 127 to 1026       900/1295
(69 %)
54 diff
(95.9 %id)
BC047793 Uterus, leiomyosarcoma .c 40 to 1944 1 to 1905 E4D K347N A437V available from MGC, AAA   1905/1905
(100 %)
4 diff
(99.8 %id)
BG825168 muscle, rhabdomyosarcoma .c 40 to 642 1 to 603       603/603
(100 %)
8 diff
(98.7 %id)
BI822438 pooled brain, lung, testis .c 41 to 124 1 to 83       83/83
(100 %)
2 diff
(97.6 %id)
BI821362 pooled brain, lung, testis .c 41 to 124 1 to 86       86/86
(100 %)
2 diff
(97.7 %id)
EL734611 mixed .c 42 to 735 1 to 689       687/690
(99 %)
12 diff
(98.3 %id)
BQ961505 leiomyosarcoma, uterus .c 42 to 791 1 to 750       750/910
(82 %)
4 diff
(99.6 %id)
BX365875 Neuroblastoma Cot 25-normalized .c 43 to 859 1 to 817       817/817
(100 %)
7 diff
(99.2 %id)
BX341746   .c 43 to 997 1 to 945   fully sequenced,   945/945
(100 %)
17 diff
(98.3 %id)
BM451664 eye, retinoblastoma .c 43 to 559 1 to 518       518/1277
(40 %)
11 diff
(99.2 %id)
BM477518 lymph, lymphoma, cell line .c 43 to 812 1 to 773       773/1080
(71 %)
9 diff
(99.2 %id)
BX394217 Neuroblastoma Cot 25-normalized .c 44 to 978 1 to 923   fully sequenced,   923/923
(100 %)
14 diff
(98.5 %id)
BI838501 pooled pancreas and spleen .c 44 to 741 1 to 699       699/699
(100 %)
7 diff
(99.0 %id)
CF552240 Pooled muscle (cardiac and skeletal) .c 44 to 864 1 to 835       835/917
(91 %)
19 diff
(98.0 %id)
CR976960 T-Lymphocytes .c 44 to 791 1 to 748       748/749
(99 %)
2 diff
(99.8 %id)
BQ055258 lymph, lymphoma, cell line .c 48 to 780 1 to 739       737/1161
(63 %)
22 diff
(98.2 %id)
BQ061606 lymph, lymphoma, cell line .c 48 to 875 1 to 834       834/1094
(76 %)
18 diff
(98.4 %id)
BM449499 leiomyosarcoma, uterus .c 49 to 409 1 to 361       361/1169
(30 %)
8 diff
(99.4 %id)
TI_57196725   .c 50 to 845 11 to 804       794/1197
(66 %)
34 diff
(97.2 %id)
BE895624 melanotic melanoma, skin .c 57 to 724 1 to 664   AAA   664/998
(66 %)
15 diff
(98.5 %id)
CN403176 embryonic stem cells, cell lines H1, H7, andH9 .c 62 to 673 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BG480039 choriocarcinoma, placenta .c 81 to 793 1 to 723       723/874
(82 %)
24 diff
(97.3 %id)
BM920097 pooled pancreas and spleen .c 81 to 1056 1 to 983       983/983
(100 %)
30 diff
(97.0 %id)
BE901844 choriocarcinoma, placenta .c 97 to 742 72 to 719       646/886
(72 %)
35 diff
(96.1 %id)
BE869890 adenocarcinoma, colon .c 98 to 840 1 to 748       748/796
(93 %)
49 diff
(93.9 %id)
BX424583 T cells (Jurkat cell line) .c 100 to 920 1 to 826       826/831
(99 %)
25 diff
(97.0 %id)
BE393302 endometrium, adenocarcinoma cell line, uterus .c 100 to 609 1 to 511       511/512
(99 %)
5 diff
(99.1 %id)
BG253358 adenocarcinoma, cell line, Liver .c 101 to 715 1 to 634       632/1043
(60 %)
38 diff
(96.4 %id)
BE278900 choriocarcinoma, placenta .c 102 to 641 1 to 540       540/541
(99 %)
1 diff
(99.9 %id)
BE409181 choriocarcinoma, placenta .c 102 to 702 1 to 600       600/603
(99 %)
6 diff
(99.1 %id)
BE266937 lung, small cell carcinoma .c 150 to 666 1 to 517       517/518
(99 %)
3 diff
(99.5 %id)
BM016875 astrocytoma grade IV, cell line, brain .c 152 to 682 1 to 531       531/532
(99 %)
2 diff
(99.7 %id)
TI_59387113   .c 152 to 682 61 to 591       531/532
(99 %)
2 diff
(99.7 %id)
DR002045 fetal brain .c 279 to 786 8 to 515       508/517
(98 %)
7 diff
(98.7 %id)
CN403174 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 286 to 984 1 to 699       699/699
(100 %)
1 diff
(99.9 %id)
BU501914 epithelioid carcinoma cell line, Pancreas .c 328 to 1156 1 to 842       842/853
(98 %)
25 diff
(97.1 %id)
BM769419 stomach .c 399 to 1105 1 to 708       711/708
(100 %)
10 diff
(98.6 %id)
BQ082727 stomach .c 399 to 967 1 to 566       569/566
(100 %)
6 diff
(99.0 %id)
BQ083658 stomach .c 399 to 959 1 to 559       562/559
(100 %)
8 diff
(98.6 %id)
BM769408 stomach .c 411 to 530 13 to 133       121/133
(90 %)
8 diff
(94.0 %id)
BQ286348 Pancreas, Purified pancreatic islet .c 424 to 911 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BE208444 lung, small cell carcinoma .c 432 to 949 1 to 518       518/527
(98 %)
3 diff
(99.5 %id)
CK825805 Pancreas, Purified pancreatic islet .c 442 to 1019 1 to 578     Submitted on the opposite strand 578/578
(100 %)
0 diff
(100 %id)
CN403175 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 445 to 1124 1 to 680       680/680
(100 %)
0 diff
(100 %id)
BE264665 lung, small cell carcinoma .c 450 to 998 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BE793028 lung, small cell carcinoma .c 452 to 1282 1 to 823       823/899
(91 %)
17 diff
(98.2 %id)
AW248186 lung, small cell carcinoma .c 454 to 865 1 to 413       413/413
(100 %)
5 diff
(98.8 %id)
BE870435 adenocarcinoma, colon .c 471 to 953 1 to 488       488/794
(61 %)
16 diff
(98.0 %id)
BE537619 cervix .c 487 to 1219 1 to 736       736/737
(99 %)
37 diff
(95.0 %id)
R14653 whole brain .c 490 to 806 1 to 318       318/321
(99 %)
2 diff
(99.4 %id)
BG825838 muscle, rhabdomyosarcoma .c 516 to 1194 1 to 707       707/740
(95 %)
38 diff
(94.9 %id)
CN484742 eye .c 519 to 1150 1 to 632       632/632
(100 %)
1 diff
(99.9 %id)
BG395939 eye, retinoblastoma .c 564 to 1290 1 to 724       724/779
(92 %)
14 diff
(98.3 %id)
BG386550 adenocarcinoma cell line, colon .c 575 to 1334 1 to 759       759/765
(99 %)
17 diff
(97.8 %id)
AA380855   .c 580 to 847 1 to 268       268/268
(100 %)
7 diff
(97.4 %id)
BX370709   .c 598 to 1469 1 to 874       874/879
(99 %)
24 diff
(97.3 %id)
BU196083 melanotic melanoma, cell line, skin .c 612 to 1361 1 to 756   tiling clone,   756/918
(82 %)
21 diff
(97.8 %id)
BU166605 melanotic melanoma, cell line, skin .c 612 to 1448 1 to 845       845/962
(87 %)
29 diff
(97.0 %id)
BE299884 muscle, rhabdomyosarcoma .c 661 to 1239 1 to 588   fully sequenced,   588/588
(100 %)
14 diff
(97.7 %id)
BE299801 muscle, rhabdomyosarcoma .c 661 to 1219 1 to 560   fully sequenced,   560/560
(100 %)
9 diff
(98.4 %id)
CV810347 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 675 to 1393 1 to 719   tiling clone,   719/720
(99 %)
8 diff
(98.9 %id)
BX332596 Neuroblastoma Cot 25-normalized .c 687 to 1385 1 to 699   fully sequenced,   699/699
(100 %)
1 diff
(99.9 %id)
BM852956 Ascites, stomach .c 687 to 872 1 to 186       186/186
(100 %)
0 diff
(100 %id)
BU162472 melanotic melanoma, cell line, skin .c 693 to 1292 1 to 600       600/1068
(56 %)
3 diff
(99.8 %id)
BU839085 melanotic melanoma, cell line, skin .c 693 to 1036 1 to 344       344/1243
(27 %)
10 diff
(99.2 %id)
BQ683499 melanotic melanoma, cell line, skin .c 693 to 986 1 to 294       294/294
(100 %)
0 diff
(100 %id)
TI_57190355   .c 719 to 1489 45 to 818       774/774
(100 %)
14 diff
(98.2 %id)
BI856389 breast, mammary adenocarcinoma, cell line .c 720 to 1489 1 to 772       772/772
(100 %)
14 diff
(98.2 %id)
BQ682659 melanotic melanoma, cell line, skin .c 779 to 1281 1 to 503       503/1095
(45 %)
20 diff
(98.2 %id)
AA300887 testis .c 853 to 1069 1 to 218       218/218
(100 %)
1 diff
(99.6 %id)
TI_159676507   .c 885 to 1807 52 to 965       914/1057
(86 %)
25 diff
(97.7 %id)
CF131401 Chondrosarcoma Lung Metastasis cell lines, lung .c 887 to 1636 1 to 750       750/750
(100 %)
7 diff
(99.1 %id)
BX325402   .c 905 to 1911 998 to 1   fully sequenced,   998/998
(100 %)
10 diff
(99.0 %id)
AL519644 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 932 to 1903 972 to 8   fully sequenced,   965/972
(99 %)
9 diff
(99.1 %id)
BX394216 Neuroblastoma Cot 25-normalized .c 948 to 1901 949 to 5   tiling clone, fully sequenced,   945/949
(99 %)
4 diff
(99.6 %id)
BX341745   .c 967 to 1881 926 to 20   fully sequenced,   907/926
(97 %)
11 diff
(98.9 %id)
BM824729 Ascites, stomach .c 975 to 1471 1 to 497       497/498
(99 %)
4 diff
(99.2 %id)
BX341741   .c 1004 to 1918 923 to 1       921/923
(99 %)
22 diff
(97.7 %id)
BI757324 brain .c 1054 to 1198 1 to 148       148/148
(100 %)
5 diff
(96.7 %id)
BM853802 Ascites, stomach .c 1083 to 1350 1 to 265       265/267
(99 %)
5 diff
(98.2 %id)
AA635009 lung, lung carcinoma .c 1088 to 1544 1 to 451       451/451
(100 %)
6 diff
(98.7 %id)
BX365874 Neuroblastoma Cot 25-normalized .c 1098 to 1907 814 to 6       809/814
(99 %)
4 diff
(99.6 %id)
TI_1948213298   .c 1115 to 1624 633 to 124       510/1367
(37 %)
9 diff
(99.4 %id)
TI_1948213020   .c 1144 to 1628 141 to 626       486/1387
(35 %)
20 diff
(98.6 %id)
BE299510 muscle, rhabdomyosarcoma .c 1189 to 1865 700 to 25   fully sequenced,   676/700
(96 %)
2 diff
(99.8 %id)
BX330391 Placenta Cot 25-normalized .c 1208 to 1931 736 to 6       731/781
(93 %)
18 diff
(97.7 %id)
BE300200 muscle, rhabdomyosarcoma .c 1209 to 1893 709 to 26   fully sequenced,   684/709
(96 %)
2 diff
(99.8 %id)
BE251582 eye, retinoblastoma .c 1239 to 1898 1 to 656       656/669
(98 %)
10 diff
(98.6 %id)
BU844738 ovary, teratocarcinoma, cell line .c 1292 to 1856 324 to 890       567/891
(63 %)
11 diff
(98.8 %id)
BU628983 cell lines, Chondrosarcoma .c 1299 to 1943 663 to 19   AAA   645/648
(99 %)
1 diff
(99.9 %id)
BX332595 Neuroblastoma Cot 25-normalized .c 1324 to 1920 597 to 1   fully sequenced,   597/597
(100 %)
4 diff
(99.4 %id)
BX109786 whole brain .c 1336 to 1948 627 to 15   AAA   613/613
(100 %)
1 diff
(99.9 %id)
AA522511 lung, lung tumor .c 1343 to 1944 588 to 1       588/826
(71 %)
22 diff
(97.4 %id)
AW247155 lung, small cell carcinoma .c 1360 to 1944 595 to 11   AAA   585/585
(100 %)
0 diff
(100 %id)
BF345244 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1376 to 1943 1 to 568       568/929
(61 %)
5 diff
(99.5 %id)
TI_149274994   .c 1390 to 1943 638 to 85   AAA   554/993
(55 %)
0 diff
(100 %id)
BU676467 lung, Primary Lung Epithelial Cells .c 1390 to 1943 572 to 19   AAA   554/562
(98 %)
0 diff
(100 %id)
BG222434 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .c 1457 to 1944 490 to 2       489/490
(99 %)
0 diff
(100 %id)
AI638136 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1461 to 1945 503 to 19   AAA   485/485
(100 %)
0 diff
(100 %id)
AI127391 heart .c 1471 to 1949 480 to 2       479/483
(99 %)
0 diff
(100 %id)
AI891063 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1476 to 1943 469 to 2       468/469
(99 %)
0 diff
(100 %id)
AI680085 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1477 to 1935 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AA568728 colon, colon tumor RER+ .c 1486 to 1944 459 to 1       459/459
(100 %)
0 diff
(100 %id)
BQ269701 Pancreas, Purified pancreatic islet .c 1517 to 1943 438 to 12   AAA   427/427
(100 %)
1 diff
(99.8 %id)
AW731877 lung, small cell carcinoma .c 1540 to 1945 409 to 4       406/409
(99 %)
0 diff
(100 %id)
AI686120 Prostate .c 1541 to 1945 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AI936193 normal prostate, Prostate .c 1541 to 1952 412 to 1       412/420
(98 %)
0 diff
(100 %id)
AA302645 adipose tissue, white .c 1545 to 1943 399 to 1       399/401
(99 %)
1 diff
(99.8 %id)
AI587215 adenocarcinoma, Pancreas .c 1575 to 1944 366 to 2       365/366
(99 %)
0 diff
(100 %id)
AW135272   .c 1602 to 1943 359 to 18   AAA   342/345
(99 %)
1 diff
(99.8 %id)
AI913915 colon .c 1628 to 1943 318 to 3       316/318
(99 %)
0 diff
(100 %id)
R45632 whole brain .c 1634 to 1948 335 to 11   AAA   325/359
(90 %)
16 diff
(95.6 %id)
AI282350 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1638 to 1945 310 to 3       308/310
(99 %)
0 diff
(100 %id)
AI281731 esophagus, squamous cell carcinoma .c 1639 to 1945 327 to 21   AAA   307/307
(100 %)
1 diff
(99.7 %id)
BQ233366 epithelioid carcinoma, Pancreas .c 1683 to 1813 13 to 143       131/155
(84 %)
10 diff
(93.6 %id)
AA370163 Prostate .c 1718 to 1945 228 to 1       228/228
(100 %)
1 diff
(99.6 %id)
AW770348 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1718 to 1945 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AA989219 carcinoid, lung .c 1743 to 1944 202 to 1       202/202
(100 %)
0 diff
(100 %id)
AI918568 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1808 to 1936 129 to 1       129/129
(100 %)
0 diff
(100 %id)
AI216620 carcinoid, lung .c 1826 to 1944 119 to 1       119/119
(100 %)
0 diff
(100 %id)
AW772162 Kidney .c 1860 to 1944 87 to 3       85/87
(97 %)
0 diff
(100 %id)
AL529318 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 1 to 847 1 to 839   tiling clone,   839/839
(100 %)
28 diff
(96.7 %id)
AL529317 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 972 to 1864 897 to 1   tiling clone,   897/897
(100 %)
28 diff
(96.9 %id)
CB990039 Human Placenta, placenta .e 1 to 664 28 to 696 A7S E116D F209I Q210P S211V ... tiling clone,   669/790
(84 %)
13 diff
(98.4 %id)
BM562308 leukocyte .f 1 to 1044 15 to 1070 exact tiling clone,   1056/1085
(97 %)
61 diff
(94.4 %id)
BI911730 leukocyte .g 1 to 777 26 to 810 G2H F3G S4L E5R Q6H ... tiling clone,   792/813
(97 %)
35 diff
(95.7 %id)
TI_57233830   .g 1 to 777 26 to 810 G2H F3G S4L E5R Q6H ...     792/813
(97 %)
35 diff
(95.7 %id)
CR996998 T-Lymphocytes .h 1 to 784 1 to 784 E4D tiling clone,   784/799
(98 %)
5 diff
(99.4 %id)
TI_57220536   .h 538 to 1357 27 to 853   tiling clone,   827/955
(86 %)
41 diff
(95.8 %id)
BX483091   .h 765 to 1342 589 to 12   tiling clone, Submitted on the opposite strand 578/657
(87 %)
0 diff
(100 %id)
AA504269 germinal center B cell .h 833 to 1335 503 to 1       503/503
(100 %)
2 diff
(99.7 %id)
AI332331 lung .h 888 to 1325 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
AI049878   .h 932 to 1331 406 to 1       406/406
(100 %)
4 diff
(99.1 %id)
AA764737 germinal center B cell .h 966 to 1335 368 to 1       368/368
(100 %)
2 diff
(99.5 %id)
AI243719 pooled .h 1022 to 1330 309 to 1       309/309
(100 %)
0 diff
(100 %id)
AW610282 stomach .h 1150 to 1433 27 to 306   tiling clone,   280/310
(90 %)
12 diff
(96.2 %id)
AW821676 stomach .h 1153 to 1433 1 to 277       277/281
(98 %)
14 diff
(95.1 %id)
CN411407 embryonic stem cells, cell lines H1, H7, andH9 .h 1388 to 2062 1 to 676   tiling clone,   676/679
(99 %)
8 diff
(98.9 %id)
BE708685 head_neck .h 1715 to 1979 274 to 11       264/300
(88 %)
7 diff
(97.7 %id)
BE708696 head_neck .h 1715 to 1979 274 to 11       264/300
(88 %)
7 diff
(97.7 %id)
BQ015999 lung, Metastatic Chondrosarcoma .h 2049 to 2703 673 to 19   tiling clone, AAA   655/664
(98 %)
4 diff
(99.4 %id)
AW967266   .h 2078 to 2485 1 to 408       408/408
(100 %)
12 diff
(97.1 %id)
DA073981 cerebellum .i 1 to 567 2 to 568 E4D R56X tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
DB297663 cerebellum .i 1044 to 1507 465 to 1   tiling clone,   465/465
(100 %)
2 diff
(99.6 %id)
BG715897 brain, hypothalamus .i 1302 to 1958 1 to 655   tiling clone,   655/655
(100 %)
17 diff
(97.5 %id)
BM753077 stomach .i 1459 to 2001 1 to 543       543/543
(100 %)
0 diff
(100 %id)
BM753241 stomach .i 1459 to 2074 1 to 614       614/614
(100 %)
3 diff
(99.6 %id)
BM765857 stomach .i 1459 to 2101 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BM772437 stomach .i 1459 to 2101 1 to 643       643/643
(100 %)
0 diff
(100 %id)
BM772825 stomach .i 1459 to 2103 1 to 645   tiling clone,   645/645
(100 %)
0 diff
(100 %id)
H53911 liver and spleen .i 1468 to 1804 1 to 340       340/344
(98 %)
6 diff
(98.3 %id)
CB156858 Liver .i 1519 to 2015 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
BG546356 lung .i 1541 to 2244 1 to 709       709/709
(100 %)
7 diff
(99.1 %id)
TI_154109307   .i 1731 to 2547 895 to 86   AAA   810/983
(82 %)
9 diff
(99.1 %id)
BY997601   .i 1788 to 2342 1 to 554       554/554
(100 %)
4 diff
(99.3 %id)
CR738439 liver and spleen .i 1803 to 2541 1 to 739   AAA   739/739
(100 %)
1 diff
(99.9 %id)
T82076 liver and spleen .i 1804 to 2164 1 to 375   fully sequenced,   375/375
(100 %)
18 diff
(95.2 %id)
T79659 liver and spleen .i 1804 to 2085 1 to 285       285/408
(69 %)
3 diff
(99.3 %id)
R09353 liver and spleen .i 1804 to 2186 1 to 392       392/392
(100 %)
12 diff
(97.0 %id)
CV362328 nervous_tumor .i 1886 to 2263 78 to 454       377/454
(83 %)
7 diff
(98.5 %id)
CA447795 Chondrosarcoma, Left Pelvis .i 1886 to 2547 675 to 13   AAA   663/663
(100 %)
2 diff
(99.7 %id)
BU628963 cell lines, Chondrosarcoma .i 1889 to 2557 687 to 19   tiling clone, AAA   669/669
(100 %)
1 diff
(99.9 %id)
T79581 liver and spleen .i 2085 to 2548 485 to 4       482/541
(89 %)
0 diff
(100 %id)
T81763 liver and spleen .i 2140 to 2477 340 to 1   fully sequenced,   340/340
(100 %)
5 diff
(98.6 %id)
H53591 liver and spleen .i 2144 to 2562 426 to 1   tiling clone,   426/426
(100 %)
12 diff
(97.2 %id)
R09238 liver and spleen .i 2243 to 2534 293 to 1       293/298
(98 %)
5 diff
(98.4 %id)
BM546804 ovary (pool of 3) .j 1 to 797 14 to 819 S148A M150H K151E P153A G154P ... tiling clone,   806/1113
(72 %)
23 diff
(98.0 %id)
BI917344 brain .k 1 to 757 1 to 753 W3L tiling clone,   753/759
(99 %)
10 diff
(98.7 %id)
TI_57244634   .k 1 to 757 37 to 789 W3L     753/795
(94 %)
15 diff
(98.2 %id)
BF592783 pooled germ cell tumors .l 1 to 503 503 to 1 R97K tiling clone,   508/508
(100 %)
1 diff
(99.9 %id)
AI341400 pooled germ cell tumors .l 229 to 503 277 to 1   tiling clone,   277/283
(97 %)
8 diff
(97.2 %id)
AA341972 muscle .m 1 to 285 1 to 286 E2A S45X H53S E55G E56R ... tiling clone,   286/286
(100 %)
5 diff
(98.3 %id)
TI_57173057   .n 1 to 612 21 to 651       631/651
(96 %)
7 diff
(99.0 %id)
BI827009 brain, medulla .n 6 to 612 1 to 626   tiling clone,   626/626
(100 %)
26 diff
(95.9 %id)
BU195971 epithelioid carcinoma, Pancreas .n 323 to 930 44 to 657 D46E T50N F51L L52P Q53A ... tiling clone,   614/823
(74 %)
15 diff
(98.2 %id)
BQ694207 adipose .o-u 1 to 453 1 to 452 exact tiling clone,   452/452
(100 %)
1 diff
(99.8 %id)
BQ694208 adipose .o-u 1 to 567 1 to 565 exact tiling clone,   565/565
(100 %)
2 diff
(99.7 %id)
AA516012 colon .o-u 62 to 435 1 to 374 exact   Submitted on the opposite strand 374/374
(100 %)
0 diff
(100 %id)
AI921826 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .p-u 1 to 528 528 to 1 W18C tiling clone,   528/528
(100 %)
1 diff
(99.9 %id)
AK094466 cerebellum Gene TSEN54, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
Z45242 brain, total brain Gene TSEN54, variant not shown         This clone was ignored    
AL515299 neuroblastoma, placenta Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
AL515300 neuroblastoma, placenta Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
AI739501 colon, colon tumor, RER+ Gene TSEN54, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI830370 colon, colon tumor, RER+ Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
BF512100   Gene TSEN54, variant not shown         This clone was ignored    
BF314782 brain, neuroblastoma Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
BG335724 choriocarcinoma, placenta Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
BG481577 choriocarcinoma, placenta Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
BC045551 Brain, hypothalamus Gene TSEN54, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
DB039647 testis Gene TSEN54, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB337724 testis Gene TSEN54, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI